3 Stocks Making Massive 1-Day Moves

These three winners and losers in the biotech space today moved big. Really big.

Mar 5, 2014 at 5:52PM

In the biotech space today, three stocks made absolutely massive moves, with each popping or dropping by more than 20% in a single day. First up is Peregrine (NASDAQ:PPHM), the day's biggest winner by far, up nearly 50% today on the announcement that it would be announcing results for its preclinical immuno-oncology drugs at an upcoming conference next week. Motley Fool health-care analyst David Williamson notes here that despite the remarkably strong interest in this space, this feels as if the market is overbuying the rumor. With the company's phase 3 drug Bavituximab having had some troubles with its phase 2 testing, this is a stock he recommends staying away from for the moment.

Today's other winner, Arrowhead Research Corp. (NASDAQ:ARWR), saw shares soar upward 25% after two Wall Street analysts showed the small-cap company some love. Deutsche Bank initiated coverage on the stock with a "buy" rating and a $45 price target. RBC also initiated coverage with a buy and a $35 price target but saw its bull case to be potentially over $60. The market is excited over the company's hepatitis B drug. David discusses what to watch with this company, and why he'll be keeping a close eye on this one.

And finally, Xoma (NASDAQ:XOMA) is today's big loser, down 25% after pausing the development of its osteoarthritis drug Gevokizumab. While this isn't completely the end for Gevokizumab, this was a very big indication for the drug. However, since the drug is being tested in a whopping 11 indications, losing just one probably doesn't warrant having the company lose a fourth of its value.

Looking for explosive growth like this in your portfolio?
They said it couldn't be done. But David Gardner has proved them wrong time, and time, and time again with stock returns like 926%, 2,239%, and 4,371%. In fact, just recently one of his favorite stocks became a 100-bagger. And he's ready to do it again. You can uncover his scientific approach to crushing the market and his carefully chosen six picks for ultimate growth instantly, because he's making this premium report free for you today. Click here now for access.

David Williamson and The Motley Fool have no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information